Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Adrenal Adenoma

Tundra lists 3 Adrenal Adenoma clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT02756754

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

The aim of the study is to evaluate the novel use of adrenal radiofrequency ablation on a prospective cohort of patients with primary aldosteronism and unilateral adrenal adenoma concerning the efficacy on blood pressure control. The safety of the procedure is one of the secondary outcomes.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-04

Primary Aldosteronism
Adrenal Adenoma
RECRUITING

NCT04890444

China Adrenal Disease Registry

Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.

Gender: All

Ages: 16 Years - 75 Years

Updated: 2022-02-14

Cushing Syndrome
Aldosteronism
Hypoadrenalism
+5
ENROLLING BY INVITATION

NCT03474237

A Prospective Cohort Study for Patients With Adrenal Diseases

The purpose of this study is to investigate the pathologic features, complications, and prognostic factors of functioning adrenal adenoma and suggest follow-up algorithms for adrenal incidentaloma.

Gender: All

Ages: 19 Years - Any

Updated: 2020-03-18

Adrenal Adenoma
Cushing Syndrome
Pheochromocytoma
+3